BioXcel Corporation has launched the latest version of its cloud-based pharma big data analytics platform – PharmGPS™ 2.0. This proprietary platform integrates BioXcel’s ApolloTRIM discovery engine with its PharmGPS™ Decision Genius platform, providing recursive-mapping capabilities for drug discovery and predictive analytics.

The company’s President and Chief Scientific Officer, Krishnan Nandabalan, and its VP, Oncology R&D, Luca Rastelli, will be showcasing the power of the PharmGPS™ Platform in their joint presentation titled ‘Big Data to Clinical Leads’ at Phacilitate’s Big Data in Clinical Development conference in Washington D.C on October 7th- 8th.